Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126750771 | 12675077 | 1 | I | 20160704 | 20160812 | 20160822 | 20160822 | EXP | FR-ALLERGAN-1666053US | ALLERGAN | 28.00 | YR | M | Y | 0.00000 | 20160822 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126750771 | 12675077 | 1 | PS | TROSPIUM CHLORIDE UNK | TROSPIUM CHLORIDE | 1 | Oral | 20 MG, QD | 21595 | 20 | MG | QD | |||||||
| 126750771 | 12675077 | 2 | SS | LOXAPAC | LOXAPINE SUCCINATE | 1 | Oral | 3 DF DOSAGE FORM EVERY DAY, AS NECESSARY | U | U | 0 | 25 | MG | TABLET | TID | ||||
| 126750771 | 12675077 | 3 | SS | DEPAKIN CHRONO | VALPROIC ACID | 1 | Oral | 1250 MG, BID | 0 | 1250 | MG | PROLONGED-RELEASE CAPSULE | BID | ||||||
| 126750771 | 12675077 | 4 | SS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 200 MG, QD | U | U | 0 | 200 | MG | TABLET | QD | ||||
| 126750771 | 12675077 | 5 | SS | RISPERIDONE MYLAN | RISPERIDONE | 1 | Oral | 6 MG, QD | U | U | 0 | 6 | MG | TABLET | QD | ||||
| 126750771 | 12675077 | 6 | SS | DIPIPERON | PIPAMPERONE | 1 | Oral | 40-20-40 | U | U | 0 | ||||||||
| 126750771 | 12675077 | 7 | SS | IMOVANE | ZOPICLONE | 1 | Oral | 7.5 MG, QD | U | U | 0 | 7.5 | MG | FILM-COATED TABLET | QD | ||||
| 126750771 | 12675077 | 8 | SS | RIVOTRIL | CLONAZEPAM | 1 | Oral | 2 MG, TID | U | U | 0 | 2 | MG | TID | |||||
| 126750771 | 12675077 | 9 | C | UVEDOSE | CHOLECALCIFEROL | 1 | U | 0 | |||||||||||
| 126750771 | 12675077 | 10 | C | SCOPODERM | SCOPOLAMINE | 1 | U | 0 | |||||||||||
| 126750771 | 12675077 | 11 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126750771 | 12675077 | 1 | Product used for unknown indication |
| 126750771 | 12675077 | 2 | Product used for unknown indication |
| 126750771 | 12675077 | 3 | Product used for unknown indication |
| 126750771 | 12675077 | 4 | Product used for unknown indication |
| 126750771 | 12675077 | 5 | Product used for unknown indication |
| 126750771 | 12675077 | 6 | Product used for unknown indication |
| 126750771 | 12675077 | 7 | Product used for unknown indication |
| 126750771 | 12675077 | 8 | Product used for unknown indication |
| 126750771 | 12675077 | 9 | Product used for unknown indication |
| 126750771 | 12675077 | 10 | Product used for unknown indication |
| 126750771 | 12675077 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126750771 | 12675077 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126750771 | 12675077 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126750771 | 12675077 | 3 | 20160712 | 0 |